...
首页> 外文期刊>Circulation research: a journal of the American Heart Association >Endothelial Cell-Specific Deficiency of Ang II Type 1a Receptors Attenuates Ang II-Induced Ascending Aortic Aneurysms in LDL Receptor-/- Mice.
【24h】

Endothelial Cell-Specific Deficiency of Ang II Type 1a Receptors Attenuates Ang II-Induced Ascending Aortic Aneurysms in LDL Receptor-/- Mice.

机译:血管紧张素Ⅱ1a型受体的内皮细胞特异性缺陷减弱了血管紧张素Ⅱ诱导的LDL受体//-小鼠升主动脉瘤。

获取原文
获取原文并翻译 | 示例

摘要

Rationale: Human studies and mouse models have provided evidence for angiotensin II (Ang II)-based mechanisms as an underlying cause of aneurysms localized to the ascending aorta. In agreement with this associative evidence, we have published recently that Ang II infusion induces aneurysmal pathology in the ascending aorta. Objective: The aim of this study was to define the role of angiotensin II type 1a (AT(1a)) receptors and their cellular location in Ang II-induced ascending aortic aneurysms (AAs). Methods and Results: Male LDL receptor(-/-) mice were fed a saturated fat-enriched diet for 1 week before osmotic mini-pump implantation and infused with either saline or Ang II (1000 ng/kg per minute) for 28 days. Intimal surface areas of ascending aortas were measured to quantify ascending AAs. Whole body AT(1a) receptor deficiency ablated Ang II-induced ascending AAs (P<0.001). To determine the role of AT(1a) receptors on leukocytes, LDL receptor(-/-)xAT(1a) receptor(+/+) or AT(1a) receptor(-/-) mice were irradiated and repopulated with bone marrow-derived cells isolated from either AT(1a) receptor(+/+) or AT(1a) receptor(-/-) mice. Deficiency of AT(1a) receptors in bone marrow-derived cells had no effect on Ang II-induced ascending AAs. To determine the role of AT(1a) receptors on vascular wall cells, we developed AT(1a) receptor floxed mice with depletion on either smooth muscle or endothelial cells using Cre driven by either SM22 or Tek, respectively. AT(1a) receptor deletion in smooth muscle cells had no effect on ascending AAs. In contrast, endothelial-specific depletion attenuated this pathology. Conclusions: Ang II infusion promotes aneurysms in the ascending aorta via stimulation of AT(1a) receptors that are expressed on endothelial cells.
机译:原理:人体研究和小鼠模型为基于血管紧张素II(Ang II)的机制提供了证据,该机制是定位于升主动脉的动脉瘤的根本原因。与此相关的证据相一致,我们最近发表了Ang II输注在升主动脉中引起动脉瘤病理的研究。目的:本研究的目的是确定血管紧张素II型1a(AT(1a))受体的作用及其在Ang II诱导的升主动脉瘤(AAs)中的细胞位置。方法和结果:雄性LDL受体(-/-)小鼠在渗透微型泵植入前接受了饱和脂肪丰富的饮食1周,并注入了盐水或Ang II(1000 ng / kg /分钟)注入28天。测量升主动脉的内膜表面积以量化升AA。全身AT(1a)受体缺乏消除了Ang II诱导的AA升高(P <0.001)。为了确定AT(1a)受体在白细胞上的作用,对LDL受体(-/-)xAT(1a)受体(+ / +)或AT(1a)受体(-/-)小鼠进行辐照,并用骨髓-从AT(1a)受体(+ / +)或AT(1a)受体(-/-)小鼠中分离得到的细胞。骨髓来源的细胞中AT(1a)受体的缺乏对Ang II诱导的升AA没有影响。为了确定AT(1a)受体在血管壁细胞上的作用,我们开发了由平滑肌或内皮细胞耗竭的AT(1a)受体浮选小鼠,分别使用SM22或Tek驱动的Cre。平滑肌细胞中的AT(1a)受体缺失对AA的上升没有影响。相反,内皮特异性消耗减弱了这种病理。结论:Ang II输注通过刺激内皮细胞表达的AT(1a)受体促进升主动脉瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号